Eastgate Biotech Corp. filed its 10-K on Apr 01, 2015 for the period ending Dec 31, 2014. In this report its auditor, Sadler, Gibb and Associates, LLC, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.009 USD | +28.57% | +12.50% | -10.00% |
1st Jan change | Capi. | |
---|---|---|
-10.00% | 9.52M | |
+21.85% | 546B | |
-4.77% | 359B | |
+16.97% | 323B | |
+5.69% | 290B | |
+13.68% | 234B | |
+3.65% | 198B | |
-11.12% | 194B | |
+8.08% | 167B | |
-3.40% | 157B |
- Stock Market
- Equities
- ETBI Stock
- News Eastgate Biotech Corp.
- Eastgate Biotech Corp. Auditor Raises 'Going Concern' Doubt